{
    "clinical_study": {
        "@rank": "18265", 
        "arm_group": [
            {
                "arm_group_label": "Control (standard) (Kabiven)", 
                "arm_group_type": "Active Comparator", 
                "description": "an isocaloric and iso-nitrogenous standard parenteral nutrition (Kabiven)"
            }, 
            {
                "arm_group_label": "Standard parenteral-glutamine (S-D)", 
                "arm_group_type": "Experimental", 
                "description": "alanine-glutamine (aln-gln) (Dipeptiven) supplemented parenteral nutrition (S-D group, n=8),"
            }, 
            {
                "arm_group_label": "Standard-Omega-3 fatty acid  (S-O)", 
                "arm_group_type": "Experimental", 
                "description": "Omega-3 fatty acid  (Omegaven) supplemented  parenteral nutrition (S-O group, n=8)"
            }, 
            {
                "arm_group_label": "Standard-glutamine-omega 3 (S-D-O)", 
                "arm_group_type": "Experimental", 
                "description": "ala-gln and omega 3 fatty ascid supplemented parenteral nutrition (S-D-O group, n=10)."
            }
        ], 
        "brief_summary": {
            "textblock": "Hypercatabolism and immune suppression are frequently seen in patients with malignancy.\n      Preoperative nutritional state is an important factor in determining surgical and\n      postoperative complications because the preoperative nutritional status  affects the\n      postoperative nutritional state, immunity and inflammatory response. In these patients,\n      standard parenteral nutrition may not be sufficient to maintain the immunity and provide\n      positive or stabilized nitrogen balance. Preoperative and perioperative supplementation with\n      immune-enhancing enteral nutrition has been reported to increase total lymphocytes and T\n      lymphocytes and decrease circulating  levels of interleukin 6 and tumor necrosis factor-\n      alfa. There is a report which showed that glutamine dipeptide supplemented parenteral\n      nutrition improved the cellular and humoral immune functions. The investigators aimed to\n      evaluate the effect of postoperative glutamine-dipeptide and/or omega 3 fatty acid\n      supplemented parenteral nutrition on the neutrophil functions and postoperative course of\n      patients with colorectal cancer."
        }, 
        "brief_title": "Nutrition for Colorectal Cancer Patients and Neutrophil Functions", 
        "completion_date": {
            "#text": "January 2008", 
            "@type": "Actual"
        }, 
        "condition": [
            "Malnutrition", 
            "Colorectal Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Colorectal Neoplasms", 
                "Malnutrition"
            ]
        }, 
        "detailed_description": {
            "textblock": "Purpose Hypercatabolism and immune suppression are frequently seen in patients with\n      malignancy.Preoperative nutritional state is an important factor in determining surgical and\n      postoperative complications because the preoperative nutritional status affects the\n      postoperative nutritional state, immunity and inflammatory response.In these patients,\n      standard parenteral nutrition may not be sufficient to maintain the immunity and provide\n      positive or stabilized nitrogen balance. Preoperative and perioperative supplementation with\n      immune-enhancing enteral nutrition has been reported to increase total lymphocytes and T\n      lymphocytes and decrease circulating levels of interleukin 6 and tumor necrosis factor-\n      alfa.There is a report which showed that glutamine dipeptide supplemented parenteral\n      nutrition improved the cellular and humoral immune functions. The investigators aimed to\n      evaluate the effect of postoperative glutamine-dipeptide and/or omega 3 fatty acid\n      supplemented parenteral nutrition on the neutrophil functions and postoperative course of\n      patients with colorectal cancer.\n\n      Condition Intervention Phase Malnutrition Colorectal Cancer Dietary Supplement:\n      Immunonutrition Phase 4\n\n      Study Type: Interventional Study Design: Prevention, Parallel Assignment, Double Blind\n      (Subject, Investigator), Randomized, N/A\n\n      Official Title: Effects Of Standard And/Or Glutamine Dipeptide And/Or Omega-3 Fatty\n      Ascid-Supplemented Parenteral Nutrition On Neutrophil Functions, Interleukin-8 Level And\n      Length Of Stay-A Double Blind,Controlled, Randomized Study\n\n      Primary Outcome Measure: Title:   neutrophil functions Time Frame:\n      perioperative,postoperative third and seventh days for change in first seven days of\n      hospital stay Description:   For comparison of four different nutrition on neutrophil\n      functions in first seven days of hospital stays.\n\n      Secondary Outcome Measures: Title:   Length of stay Time Frame:   Length of stay\n      (participants will be followed for the duration of hospital stay) for colorectal cancer\n      patients which are eligable for study study from january 2007 to january 2008 in one year\n      period.\n\n      Description:   For comparison of four different nutrition on length of stay (participants\n      will be followed for the duration of hospital stay)\n\n      Actual Enrollment: 36 Study Start Date: January 2007 Actual Study Completion Date: January\n      2008 Actual Primary Completion Date: January 2008\n\n      Arms Assigned Interventions Active Comparator: Control an isocaloric and iso-nitrogenous\n      standard parenteral nutrition\n\n      Dietary Supplement: Immunonutrition Parenteral nutrition provided 25-30 kcal/kg/day energy\n      and 0.15-0.20 g/kg/day nitrogen. The dose of omega 3 fatty acid supplementation was 0.1-0.2\n      g/kg /day and it was 0.3-0.4 g/kg/day for glutamine dipeptide supplementation. All nutrient\n      substrates were mixed in 3 litre bags and infused in 24 h through a dedicated central venous\n      line\n\n      Experimental: Standard parenteral-glutamine (S-D) alanine-glutamine (aln-gln) (Dipeptiven)\n      supplemented parenteral nutrition (S-D group, n=8),\n\n      Dietary Supplement: Immunonutrition Parenteral nutrition provided 25-30 kcal/kg/day energy\n      and 0.15-0.20 g/kg/day nitrogen. The dose of omega 3 fatty acid supplementation was 0.1-0.2\n      g/kg /day and it was 0.3-0.4 g/kg/day for glutamine dipeptide supplementation. All nutrient\n      substrates were mixed in 3 litre bags and infused in 24 h through a dedicated central venous\n      line\n\n      Experimental: Standard-Omega-3 fatty acid (S-O) Omega-3 fatty acid (Omegaven) supplemented\n      parenteral nutrition (S-O group, n=8)\n\n      Dietary Supplement: Immunonutrition Parenteral nutrition provided 25-30 kcal/kg/day energy\n      and 0.15-0.20 g/kg/day nitrogen. The dose of omega 3 fatty acid supplementation was 0.1-0.2\n      g/kg /day and it was 0.3-0.4 g/kg/day for glutamine dipeptide supplementation. All nutrient\n      substrates were mixed in 3 litre bags and infused in 24 h through a dedicated central venous\n      line\n\n      Experimental: Standard-glutamine-omega 3 (S-D-O) ala-gln and omega 3 fatty ascid\n      supplemented parenteral nutrition (S-D-O group, n=10).\n\n      Dietary Supplement: Immunonutrition Parenteral nutrition provided 25-30 kcal/kg/day energy\n      and 0.15-0.20 g/kg/day nitrogen. The dose of omega 3 fatty acid supplementation was 0.1-0.2\n      g/kg /day and it was 0.3-0.4 g/kg/day for glutamine dipeptide supplementation. All nutrient\n      substrates were mixed in 3 litre bags and infused in 24 h through a dedicated central venous\n      line"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Colorectal cancer patients who were included study were between 50 and 70 years old\n\n        Exclusion Criteria:\n\n          -  preoperatively suffered from serious comorbid chronic  disease and received\n             chemotherapy and radiotherapy\n\n          -  immunosuppressive and /or immunomodulator  drugs in last 6 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01831310", 
            "org_study_id": "Canturkz1", 
            "secondary_id": "KOUNutrition1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Control (standard) (Kabiven)", 
                "description": "Parenteral nutrition provided 25-30 kcal/kg/day energy and 0.15-0.20 g/kg/day nitrogen. All nutrient substrates were mixed in 3 litre bags and infused in 24 h through a dedicated central venous line", 
                "intervention_name": "Standard (Kabiven)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Standard parenteral-glutamine (S-D)", 
                "description": "Parenteral nutrition (Kabiven) provided 25-30 kcal/kg/day energy and 0.15-0.20 g/kg/day nitrogen. it was 0.3-0.4 g/kg/day for glutamine dipeptide (Dipeptiven) supplementation. All nutrient substrates were mixed in 3 litre bags and infused in 24 h through a dedicated central venous line", 
                "intervention_name": "Standard-Glutamine", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Standard (Kabiven)-Glutamine (Dipeptiven)"
            }, 
            {
                "arm_group_label": "Standard-Omega-3 fatty acid  (S-O)", 
                "description": "Parenteral nutrition (Kabiven) provided 25-30 kcal/kg/day energy and 0.15-0.20 g/kg/day nitrogen. The dose of omega 3 fatty acid (omegaven)supplementation was 0.1-0.2 g/kg /day. All nutrient substrates were mixed in 3 litre bags and infused in 24 h through a dedicated central venous line", 
                "intervention_name": "Standard-Omega 3 fatty acid", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Standard (Kabiven)-Omega 3 fatty acid(Omegaven)"
            }, 
            {
                "arm_group_label": "Standard-glutamine-omega 3 (S-D-O)", 
                "description": "Parenteral nutrition (kabiven) provided 25-30 kcal/kg/day energy and 0.15-0.20 g/kg/day nitrogen. The dose of omega 3 fatty acid (omegaven) supplementation was 0.1-0.2 g/kg /day and it was 0.3-0.4 g/kg/day for glutamine dipeptide (dipeptiven)supplementation. All nutrient substrates were mixed in 3 litre bags and infused in 24 h through a dedicated central venous line", 
                "intervention_name": "Standard-glutamine-omega 3", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Standard (Kabiven)-glutamine (Dipeptiven)-omega 3 (Omegaven)"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Colorectal cancer", 
            "nutrition", 
            "neutrophil phagocytosis", 
            "neutrophil adhesivity", 
            "glutamine", 
            "omega 3 fatty acids"
        ], 
        "lastchanged_date": "April 10, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Kocaeli", 
                    "country": "Turkey", 
                    "zip": "41300"
                }, 
                "name": "Kocaeli University School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effects Of Standard And/Or Glutamine Dipeptide And/Or Omega-3 Fatty Ascid-Supplemented Parenteral Nutrition On Neutrophil Functions, Interleukin-8 Level And Length Of Stay-A Double Blind,Controlled, Randomized Study", 
        "overall_official": {
            "affiliation": "Kocaeli University", 
            "last_name": "Mustafa Dulger, Professor", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "For comparison of four different nutrition on neutrophil functions in first seven days of hospital stays.", 
            "measure": "neutrophil functions", 
            "safety_issue": "Yes", 
            "time_frame": "perioperative,postoperative third and seventh days for change in first seven days of hospital stay"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01831310"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Kocaeli University", 
            "investigator_full_name": "Nuh Zafer Cant\u00fcrk", 
            "investigator_title": "Professor in Surgical Oncology and head of Nutrition Team", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "For comparison of four different nutrition on length of stay (participants will be followed for the duration of hospital stay)", 
            "measure": "Length of stay", 
            "safety_issue": "Yes", 
            "time_frame": "Length of stay (participants will be followed for the duration of hospital stay) for colorectal cancer patients which are eligable for study study  from january 2007 to january  2008 in one year period."
        }, 
        "source": "Kocaeli University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kocaeli University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2007", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}